youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
ALC:NYSE
Alcon AG
74,94 $
arrow_downward
-2,10%(-1,61) 1D
74,94 $
0,00% (0,00)
bedtimeAfter hours
Closed: 6 қар., 16:00:06 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
74,24 $
High
75,23 $
Low
74,01 $
Mkt. cap
30,62 млрд
Avg. vol.
1,83 млн
Volume
3,17 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
Open
74,24 $
High
75,23 $
Low
74,01 $
Mkt. cap
30,62 млрд
Avg. vol.
1,83 млн
Volume
3,17 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
News stories
From web sources and news partners
Zacks
·
2 күн бұрын
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 мың
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com